LQDA
Liquidia Corporation
NASDAQ · Healthcare · Biotechnology · US
$68.66
+0.04%Forward multiples
Based on analyst estimates
- P/E forward
- 15.42x
- P/E 2026E
- 22.46x
- P/E 2027E
- 12.38x
- P/E 2028E
- 10.51x
- P/S forward
- 6.17x
Trailing multiples
Trailing twelve months
- P/E TTM
- 43.76x
- PEG TTM
- 0.24x
- Price / book
- 31.50x
- Price / sales
- 13.63x
- Price / cash flow
- 77.76x
Enterprise value
- Enterprise value
- $6.0B
- EV / sales
- 13.29x
- EV / EBITDA
- 33.69x
- EV / EBIT
- 35.54x
- Market cap
- $6.1B
Trailing, forward and enterprise-value multiples for the requested listing · Data as of Jun 1, 2026